In the Half Year they said:
Just thought some people may be interested in a clinical trial result published on the use of Tenecteplase in stroke patients which enrolled 458 patients. Its result concluded it did not result in better clinical outcomes. I thought people might be interested as I expect Clinuvel will eventually have to conduct a similar structured trial for Prenumbra.
Tenecteplase for Stroke at 4.5 to 24 Hours with Perfusion-Imaging Selection
Source: Tenecteplase for Stroke at 4.5 to 24 Hours with Perfusion-Imaging Selection | NEJM
Regards
SP
In the Half Year they said: [ATTACH] Just thought some people...
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.05 |
Change
0.050(0.36%) |
Mkt cap ! $703.5M | |||
| Open | High | Low | Value | Volume |
| $14.00 | $14.07 | $13.89 | $342.4K | 24.49K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1250 | $13.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.05 | 97 | 1 |
View Market Depth
| Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
| CUV (ASX) Chart |